JC
Highly rated in
27
conditions

Dr. Joel M. Charrow

Ann & Robert H. Lurie Children's Hospital Of Chicago
Chicago, IL
Highly rated in
27
conditions
Specialties:Pediatrics | Medical Genetics
Experience:47 Years
Clinical Trials:Currently Recruiting for 1 Trial
Accepts:New PatientsMedicare
Highly rated in
27
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Joel M. Charrow's experience treating your condition:
About Dr. Joel M. Charrow

Joel Charrow is a Pediatrics specialist and a Medical Genetics expert in Chicago, Illinois. Charrow has been practicing medicine for over 47 years and is highly rated in 27 conditions, according to our data. His top areas of expertise are Gaucher Disease Type 1, Gaucher Disease, Gaucher Disease Type 2, and Gaucher Disease Type 3. He is licensed to treat patients in Illinois. Charrow is currently accepting new patients.

His clinical research consists of co-authoring 76 peer reviewed articles and participating in 6 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Joel M. Charrow it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Joel M. Charrow accepts the following insurance:

  •  Ambetter
Call to see if your plan is accepted.
Locations
225 E Chicago Ave, Chicago, IL 60611
Background & Education
Graduate Institution
Other, 1976
Specialties
Pediatrics
Medical Genetics
Licenses
Clinical Biochemical Genetics in IL
Hospital Affiliations
Northwestern Memorial Hospital
Ann & Robert H Lurie Childrens Hospital Of Chicago
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials
A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study to Assess the Safety and Tolerability of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy, in Subjects With Fabry Disease
Enrollment Status: Recruiting
Publish Date: November 03, 2022
Intervention Type: Biological
Study Drug: ST-920
Study Phase: Phase 1/Phase 2
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
Enrollment Status: Active, not recruiting
Publish Date: December 15, 2022
Intervention Type: Drug
Study Drug: PEG-Zilarginase
Study Phase: Phase 3
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Biological
Study Drugs: PRX-102 (Pegunigalsidase Alfa)Agalsidase Beta
Study Phase: Phase 3
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Enrollment Status: Active, not recruiting
Publish Date: June 21, 2022
Intervention Type: Drug
An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment With Velaglucerase Alfa on Bone-related Pathology in Treatment-naïve Patients With Type 1 Gaucher Disease
Enrollment Status: Completed
Publish Date: February 01, 2022
Intervention Type: Dietary Supplement, Drug
Study Phase: Phase 4
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials -
76 Total Publications
Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 20, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
CP
Dr. Carlos E. Prada
Pediatrics | Medical Genetics
Highly rated in
24
conditions
Pediatrics
Medical Genetics

Cincinnati Childrens Hospital Medical Center

Ann & Robert H. Lurie Children's Hospital Of Chicago

225 E Chicago Ave, 
Chicago, IL 

Carlos Prada is a Pediatrics specialist and a Medical Genetics expert in Chicago, Illinois. Prada has been practicing medicine for over 20 years and is highly rated in 24 conditions, according to our data. His top areas of expertise are RASopathies, Noonan Syndrome, Neurofibromatosis, and Gaucher Disease Type 2. He is licensed to treat patients in Illinois. Prada is currently accepting new patients.

AP
Dr. Amy S. Paller
Pediatrics | Dermatology
Highly rated in
65
conditions
Pediatrics
Dermatology

Outpatient Center In Northbrook

1131 Techny Rd, 
Northbrook, IL 
 18.0 mi

Amy Paller is a Pediatrics specialist and a Dermatologist in Northbrook, Illinois. Paller has been practicing medicine for over 45 years and is highly rated in 65 conditions, according to our data. Her top areas of expertise are Atopic Dermatitis, Nonbullous Congenital Ichthyosiform Erythroderma, Lamellar Ichthyosis, and Netherton Syndrome. She is licensed to treat patients in Illinois. Paller is currently accepting new patients.

NK
Dr. Nancy L. Kuntz
Pediatrics | Neurology
Highly rated in
14
conditions
Pediatrics
Neurology

Ann & Robert H. Lurie Children's Hospital Of Chicago

225 E Chicago Ave, 
Chicago, IL 

Nancy Kuntz is a Pediatrics specialist and a Neurologist in Chicago, Illinois. Kuntz has been practicing medicine for over 48 years and is highly rated in 14 conditions, according to our data. Her top areas of expertise are Tubular Aggregate Myopathy, Congenital Fiber-Type Disproportion, X-Linked Myotubular Myopathy, and Spinal Muscular Atrophy (SMA). She is licensed to treat patients in Minnesota. Kuntz is currently accepting new patients.